Antimicrobial proteinaceous compounds obtained from bifidobacteria: From production to their application

International Journal of Food Microbiology

Volumn 125, Issue 3, 2008, Pages 215-222

  Cheikhyoussef, Ahmad ^a   Pogori, Natascha ^b   Chen, Wei ^a   Zhang, Hao ^a  

^a JIANGNAN UNIVERSITY   (China)

^b UNIVERSITY OF NAMIBIA   (Namibia)

Author keywords

Adhesion; Antimicrobial compounds; Bacteriocin like compound; Bacteriocins; Bifidobacteria

Indexed keywords

BACTERIOCIN; BIFIDIN; BIFIDOCIN; BIFIDOCIN B; BIFLONG; FOOD PRESERVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; SIDEROPHORE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIMICROBIAL ACTIVITY; BACTERIAL CELL WALL; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BACTERIUM CULTURE; BIFIDOBACTERIUM; CELL STRAIN CACO 2; DIET SUPPLEMENTATION; DRUG IDENTIFICATION; DRUG PURIFICATION; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI O157; FOOD MICROBIOTECHNOLOGY; FOOD SAFETY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INCUBATION TIME; INFECTION RISK; ISOELECTRIC POINT; NONHUMAN; PH MEASUREMENT; POLYACRYLAMIDE GEL ELECTROPHORESIS; REVIEW; RISK REDUCTION; SEQUENCE HOMOLOGY; SOUTHERN BLOTTING;

ANTI-BACTERIAL AGENTS; ANTIBIOSIS; BACTERIA; BACTERIAL ADHESION; BACTERIAL INFECTIONS; BACTERIOCINS; BIFIDOBACTERIUM; CONSUMER PRODUCT SAFETY; FOOD PRESERVATION; GASTROINTESTINAL TRACT; HUMANS; MICROBIAL SENSITIVITY TESTS;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM;

EID: 47349123243     PISSN: 01681605     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijfoodmicro.2008.03.012     Document Type: Review

References (82)

1. Abd El-Salam M.H., Saleh F.A., Kholif A.M., El-Sayed E.M., Abdou S.M., and El-Shibiny S. Isolation and characterization of bacteriocins produced by Bifidobacterium lactis BB-12 and Bifidobacterium longum BB-46. 9th Egyptian Conference for Dairy Science and Technology, Cairo, Egypt (2004) 9-11 October
2. Anand S.K., Srinivasan R.A., and Rao L.K. Antimicrobial activity associated with Bifidobacterium bifidum-I. Cultured Dairy Products Journal 2 (1984) 6-7
3. Anand S.K., Srinivasan R.A., and Rao L.K. Antimicrobial activity associated with Bifidobacterium bifidum-II. Cultured Dairy Products Journal 2 (1985) 21-23
4. Ballongue J. Bifidobacteria and probiotic action. In: Salminen S., and Von Wright A. (Eds). Lactic Acid Bacteria: Microbiology and Functional Aspects (1998), Marcel Dekker, New York 519-587
5. Bernet-Camard M.F., Brassart D., Neeser J.R., and Servin A.L. Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions. Applied and Environmental Microbiology 59 (1993) 4121-4128
6. Bernet-Camard M.F., Liévin V., and Brassart D. The probiotic human Lactobacillus acidophilus strain La1 secretes antibacterial substances active in vitro and in vivo. Applied and Environmental Microbiology 63 (1997) 2747-2753
7. Bevilacqua L., Ovidi M., Mattia E.D., Trovatelli L.D., and Canganella F. Screening of Bifidobacterium strains isolated from human faeces for antagonistic activities against potentially bacterial pathogens. Microbiological Research 158 (2003) 179-185
8. Bhunia A., Johnson M.C., Ray B., and Kalchanand N. Mode of action of pediocin AcH from Pediococcus acidilactici H on sensitive bacterial strains. Journal of Applied Bacteriology 70 (1991) 25-33
9. Bibiloni R., Perez P.F., Garrote G.L., Disalvo E.A., and De Antoni G.L. Surface characterization and adhesive properties of bifidobacteria. Methods in Enzymology 336 (2001) 411-427
10. Bielecka M., Biedrzycka E., Biedrzycka E., Smoragiewicz W., and Smieszek M. Interaction of Bifidobacterium and Salmonella during associated growth. International Journal of Food Microbiology 45 (1998) 151-155
11. Boris S., and Barbés C. Role played by Lactobacilli in controlling the population of vaginal pathogens. Microbes and Infection 2 (2000) 543-546
12. Bruno F.A., and Shah N.P. Inhibition of pathogenic and putrefactive microorganisms by Bifidobacterium sp. Milchwissenschaft 57 (2002) 617-621
13. Chauvière G., Coconnier M.H., and Kernéis S. Competitive exclusion of diarrheagenic Escherichia coli (ETEC) from enterocyte-like Caco-2 cells in culture. FEMS Microbiology Letters 91 (1992) 213-218
14. Chauvière G., Coconnier M.H., Kernéis S., Fourniat J., and Servin A.L. Adherence of human Lactobacillus acidophilus onto human enterocyte-like cells, Caco-2 and HT-29 in culture. Journal of General Microbiology 138 (1992) 1689-1696
15. Cheikhyoussef A., Pogori N., and Zhang H. Study of the inhibition effects of Bifidobacterium supernatants towards growth of Bacillus cereus and Escherichia coli. International Journal of Dairy Science 2 (2007) 116-125
16. Chou C.C., and Hou J.W. Growth of bifidobacteria in soymilk and their survival in the fermented soymilk drink during storage. International Journal of Food Microbiology 56 (2000) 113-121
17. Cleveland J., Montville T.J., Nes I.F., and Chikindas M.L. Bacteriocins: safe, natural antimicrobials for food preservation. International Journal of Food Microbiology 71 (2001) 1-20
18. Coconnier M.H., Liévin V., and Bernet-Camard M.F. Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB. Antimicrobial Agents and Chemotherapy 41 (1997) 1046-1052
19. Collado M.C., Hernández M., and Sanz Y. Production of bacteriocin-like compounds by human fecal Bifidobacterium strains. Journal of Food Protection 68 (2005) 1034-1040
20. Collado M.C., González A., González R., Hernández M., Ferrús M.A., and Sanz Y. Antimicrobial peptides are among the antagonistic metabolites produced by Bifidobacterium against Helicobacter pylori. International Journal of Antimicrobial Agents 25 (2005) 385-391
21. Degnan A.J., Buyong N., and Luchansky J.B. Antilisterial activity of pediocin AcH in model food systems in the presence of an emulsifier or encapsulated within liposomes. International Journal of Food Microbiology 18 (1993) 127-138
22. Del Re B., Sgorbati B., Miglioli M., and Palenzona D. Adhesion, autoaggregation and hydrophobicity of 13 strains of Bifidobacterium longum. Letters in Applied Microbiology 31 (2000) 438-442
23. De Souza E.L., Da Silva C.A., and De Sousa C.P. Bacteriocins: molecules of fundamental impact on the microbial ecology and potential food preservatives. Brazilian Archives of Biology and Technology 48 (2005) 559-566
24. De Vuyst L., Avonts L., and Makras L. Probiotics, prebiotics and gut health. In: Remacle C., and Reusens B. (Eds). Functional Foods, Ageing and Degenerative Disease (2004), Woodhead Publishing, Cambridge 416-482
25. Faure J.C., Schellenberg D., Bexter A., and Wurzner H.P. Barrier effect of Bifidobacterium longum on Escherichia coli in the germ-free rat. International Journal for Vitamin and Nutrition Research 52 (1982) 225-230
26. Fujiwara S., Hashiba H., Hirota T., and Forstner J.F. Proteinaceous factor(s) in culture supernatant fluids of bifidobacteria which prevents the binding of enterotoxigenic Escherichia coli to gangliotetraosylceramide. Applied and Environmental Microbiology 63 (1997) 506-512
27. Fujiwara S., Hashiba H., Hirota T., and Forstner J.F. Purification and characterization of a novel protein produced by Bifidobacterium longum SBT2928 that inhibits the binding of enterotoxigenic Escherichia coli Pb176 (CFA/II) to gangliotetraosylceramide. Journal of Applied Microbiology 86 (1999) 615-621
28. Fujiwara S., Hashiba H., Hirota T., and Forstner J.F. Inhibition of the binding of enterotoxigenic Escherichia coli Pb176 to human intestinal epithelial cell line HCT-8 by an extracellular protein fraction containing BIF of Bifidobacterium longum SBT2928: suggestive evidence of blocking of the binding receptor gangliotetraosylceramide on the cell surface. International Journal of Food Microbiology 67 (2001) 97-106
29. Fuller R. Probiotics in man and animals. Journal of Applied Bacteriology 66 (1989) 365-378
30. Gagnon M., Kheadr E.E., Le Blay G., and Fliss I. In vitro inhibition of Escherichia coli O157:H7 by bifidobacterial strains of human origin. International Journal of Food Microbiology 92 (2004) 69-78
31. Gagnon M., Kheadr E.E., Dabour N., Richard D., and Fliss I. Effect of Bifidobacterium thermacidophilum probiotic feeding on enterohemorrhagic Escherichia coli O157:H7 infection in BALB/c mice. International Journal of Food Microbiology 111 (2006) 26-33
32. Geis A., Singh J., and Teuber M. Potential of lactic streptococci to produce bacteriocin. Applied and Environmental Microbiology 45 (1983) 205-211
33. Gibson G.R., and Wang X. Regulatory effects of bifidobacteria on the growth of other colonic bacteria. Journal of Applied Bacteriology 77 (1994) 412-420
34. Goldin B.R., and Gorbach S.L. Probiotics for humans. In: Fuller R. (Ed). Probiotics: The Scientific Basis (1992), Chapman & Hall, London 357-359
35. Gomes A.M.P., and Malcata F.X. Bifidobacterium spp. and Lactobacillus acidophilus: biological, biochemical, technological and therapeutical properties relevant for use as probiotics. Trends in Food Science and Technology 10 (1999) 139-157
36. Gopal P.K., Prasad J., Smart J., and Gill H.S. In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli. International Journal of Food Microbiology 67 (2001) 207-216
37. Graham D.Y. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology 113 (1997) 1983-1991
38. Hamilton-Miller J.M.T. The role of probiotics in the treatment and prevention of Helicobacter pylori infection. International Journal of Antimicrobial Agents 22 (2003) 360-366
39. He F., Ouwehand A.C., Isolauri E., Hashimoto H., Benno Y., and Salminen S. Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunology and Medical Microbiology 30 (2001) 43-47
40. Henriksson A., Szewzyk R., and Conway P.L. Characteristics of the adhesive determinants of Lactobacillus fermentum 104. Applied and Environmental Microbiology 57 (1991) 499-502
41. Hou J.W., Yu R.C., and Chou C.C. Changes in some components of soymilk during fermentation with bifidobacteria. Food Research International 33 (2000) 393-397
42. Hudault S., Liévin V., and Bernet-Camard M.F. Antagonistic activity in vitro and in vivo exerted by Lactobacillus casei (strain GG) against Salmonella typhimurium infection. Applied and Environmental Microbiology 63 (1997) 513-518
43. Horrange K., Brismar B., and Nord C.E. Effects of supplements with Bifidobacterium longum and Lactobacillus acidophilus on the intestinal microbiota during administration of clindamycin. Microbial Ecology in Health and Disease 7 (1994) 17-25
44. Hoyos A.B. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. International Journal of Infectious Diseases 3 (1999) 197-202
45. Hughes D.B., and Hoover D.G. Bifidobacteria: their potential for use in American dairy products. Food Technology 45 (1991) 74-83
46. Ibrahim S., and Bezkorovainy A. Inhibition of Escherichia coli by bifidobacteria. Journal of Food Protection 56 (1993) 713-715
47. Ibrahim S.A., and Salameh M.M. Simple and rapid method for screening antimicrobial activities of Bifidobacterium species of human isolates. Journal of Rapid Methods and Automation in Microbiology, 9 (2001) 52-63
48. Ishibashi N., Yaeshima T., and Hayasawa H. Bifidobacteria: their significance in human intestinal health. Malaysian Journal of Nutrition 3 (1997) 149-159
49. Kang K.H., Shin H.J., Park Y.H., and Lee T.S. Studies on the antibacterial substances produced by lactic acid bacteria: purification and some properties of antibacterial substance 'Bifilong' produced by B. longum. Korean Dairy Science 1 (1989) 204-216
50. Keren T., Yarmus M., Halevy G., and Shapira R. Immunodetection of the bacteriocin lactacin RM: analysis of the influence of temperature and Tween 80 on its expression and activity. Applied and Environmental Microbiology 70 (2004) 2098-2104
51. Klaenhammer T.R. Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiological Reviews 12 (1993) 39-85
52. Lakhtin V.M., Aleshkin V.A., Lakhtin M.V., Afanas'ev S.S., Pospelova V.V., and Shenderov B.A. Lectins, adhesins, and lectin-like substances of lactobacilli and bifidobacteria. Vestn Ross Akad Med Nauk 1 (2006) 28-34 (in Russian)
53. Lee Y.J., Yu W.K., and Heo T.R. Identification and screening for antimicrobial activity against Clostridium difficile of Bifidobacterium and Lactobacillus species isolated from healthy infant faeces. International Journal of Antimicrobial Agents 21 (2003) 340-346
54. Liévin V., Peiffer I., Hudault S., Rochat F., Brassart D., Neeser J.R., and Servin A.L. Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut 47 (2000) 646-652
55. Makras L., and De Vuyst L. The in vitro inhibition of Gram-negative pathogenic bacteria by bifidobacteria is caused by the production of organic acids. International Dairy Journal 16 (2006) 1049-1057
56. Matsumoto M., Tani H., Ono H., Ohishi H., and Benno Y. Adhesive property of Bifidobacterium lactis LKM512 and predominant bacteria of intestinal microflora to human intestinal mucin. Current Microbiology 44 (2002) 212-215
57. Meghrous J., Euloge P., Junelles A.M., Ballongue J., and Petitidemange H. Screening of Bifidobacterium strains for bacteriocins production. Biotechnology Letters 12 (1990) 575-580
58. Misra A.K., and Kuila R.K. Antimicrobial substances from Bifidobacterium bifidum. Indian Journal Dairy Science 48 (1995) 612-614
59. Mitsuoka T. Bifidobacteria and their role in human health. Journal of Industrial Microbiology 6 (1990) 263-268
60. Moroni O., Kheadr E., Boutin Y., Lacroix C., and Fliss I. Inactivation of adhesion and invasion of food-borne Listeria monocytogenes by bacteriocin-producing Bifidobacterium strains of human origin. Applied and Environmental Microbiology 72 (2006) 6894-6901
61. Naghmouchi K., Kheadr E., Lacroix C., and Fliss I. Class I/Class IIa bacteriocin cross-resistance phenomenon in Listeria monocytogenes. Food Microbiology 24 (2007) 718-727
62. O'Riordan K., and Fitzgerald G.F. Evaluation of Bifidobacteria for the evaluation of antimicrobial compounds and assessment of performance in cottage cheese at refrigeration temperature. Journal of Applied Microbiology 85 (1998) 103-114
63. O' Sullivan, 2004. Isolated bifidobacteria that produce siderophores which inhibit growth of Lactococcus lactis, US patent No. 6,746,672 B2.
64. Oyarzabal O.A., and Conner D.E. In vitro fructooligosaccharide utilization and inhibition of Salmonella spp. by selected bacteria. Poultry Science 74 (1995) 1418-1425
65. Ozbas Z.Y., and Aytac S.A. Behavior of Yersinia enterocolitica and Aeromonas hydrophila in yogurt made with probiotic bacteria: Bifidobacterium infantis and Lactobacillus acidophilus. Milchwissenschaft 50 (1995) 626-629
66. Pucci M.J., Vedamuthu E.R., Kunka B.S., and Vandenbergh P.A. Inhibition of Listeria monocytogenes by using bacteriocin PA-I produced by Pediococcus acidilactici PAC1. Applied and Environmental Microbiology 54 (1988) 2349-2353
67. Salminen S., Ouwehand A.C., Benno Y., and Lee J.K. Probiotics: how should they be defined?. Trends Food Science and Technology 10 (1999) 107-110
68. Servin A.L. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiology Reviews 28 (2004) 405-440
69. Sgorbati B., Biavati B., and Palenzona D. The genus 'Bifidobacterium'. In: Wood B.J.B., and Holzapfel W.H. (Eds). The Lactic Acid Bacteria. The Genera of Lactic Acid Bacteria vol. 2 (1995), Blackie Academic, London 279-306
70. Silva M., Jacobus N.V., and Deneke C. Antimicrobial substance from a human Lactobacillus strain. Antimicrobial Agents and Chemotherapy 31 (1987) 1231-1233
71. Ten Brink B., Minekus M., Van der Vossen J.M.B.M., Leer R.J., Huis in, and t Veld J.H.J. Antimicrobial activity of lactobacilli: preliminary characterization and optimization of production of acidocin B, a novel bacteriocin produced by Lactobacillus acidophilus M46. Journal of Applied Microbiology 77 (1994) 140-148
72. Tagg J.R., Dajani A.S., and Wannamaker L.W. Bacteriocins of gram-positive bacteria. Bacteriological reviews 40 (1976) 722-756
73. Tissier, H., 1900. Recherchers sur la flora intestinale normale et pathologique du nourisson. Thesis, University of Paris, Paris, France.
74. Touré R., Kheadr E., Lacroix C., Moroni O., and Fliss I. Production of antibacterial substances by bifidobacterial isolates from infant stool active against Listeria monocytogenes. Journal of Applied Microbiology 95 (2003) 1058-1069
75. Trejo F.M., Minnaarda J., Pereza P.F., and De Antoni G.L. Inhibition of Clostridium difficile growth and adhesion to enterocytes by Bifidobacterium supernatants. Anaerobe 12 (2006) 186-193
76. Vandenbergh P.A. Lactic acid bacteria, their metabolic products and interference with microbial growth. FEMS Microbiology Reviews 12 (1993) 221-238
77. Velraeds M.C., Van der Mei H.C., Reid G., and Busscher H.J. Inhibition of initial adhesion of uropathogenic Enterococcus faecalis by biosurfactants from Lactobacillus isolates. Applied and Environmental Microbiology 62 (1996) 1958-1963
78. Wells C.L., Maddaus L.A., Jechorek R.P., and Simmons R.L. Role of intestinal anaerobic bacteria in colonization resistance. European Journal of Clinical Microbiology and Infectious Diseases 7 (1988) 107-113
79. Wicken A.J., and Knox K.W. Lipoteichoic acid: a new class of bacterial antigen. Science 187 (1975) 1161-1167
80. Yadiz A.M., Ali A.M., Kalaivani V., and Shuhaimi M. Properties of Bifidobacterium spp.: antibacterial, growth in milk and survival during low temperature storage. Asia-Pacific Journal of Molecular Biology and Biotechnology 6 (1998) 153-159
81. Yildirim Z., and Johnson M.G. Characterization and antimicrobial spectrum of bifidocin B, a bacteriocin produced by Bifidobacterium bifidum NCFB 1454. Journal of Food Protection 61 (1998) 47-51
82. Yildirim Z., Winters D.K., and Johnson M.G. Purification, amino acid sequence and mode of action of bifidocin B produced by Bifidobacterium bifidum NCFB 1454. Journal of Applied Microbiology 86 (1999) 45-54